You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Zymo Research said that the Quick SARS-CoV-2 rRT-PCR kit includes ready-to-use reaction mixtures that reduce hands-on time and eliminate human errors during the set-up process.
The federal agency approved the use of the Zymo Research SARS-CoV-2 kit with both upper respiratory and lower respiratory specimens.
The partners will launch Zymo's DreamPrep NAP workstation to streamline DNA/RNA extraction for high-complexity testing labs running COVID-19 assays.
Last week's SynBioBeta conference was indicative of the high degree of interest in the synthetic bio space from omics research tool vendors.
The test uses qPCR to measure the methylation level of three bladder cancer-specific biomarkers in patient urine samples.
The companies will combine their respective technologies into a single product offering for microbiome analysis.
The distribution agreement covers Zymo's nucleic acid products, including ones for DNA purification, RNA extraction, and microbiomic analysis.
Zymo said it has already created optimized methods for microbiomics and RNA isolation for use on Hamilton's platforms.
The DNA methylation age concept, developed by UCLA geneticist Steve Horvath, uses 353 markers obtained from Illumina methylation arrays.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.